Arthritis Research & Therapy

official impact factor 4.36

Open Access Highly Access Research article

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

Xenofon Baraliakos, Joachim Listing, Jan Brandt, Martin Rudwaleit, Joachim Sieper and Juergen Braun*

Arthritis Research & Therapy 2005, 7:R439-R444 doi:10.1186/ar1693

No comments have yet been made on this article.

Post a comment